HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yew, K.-H. Articles by Gittes, G. K. Search for Related Content PubMed PubMed Citation Articles by Yew, K.-H. Articles by Gittes, G. K. Social Bookmarking                What's this?

Interplay of Glucagon-Like Peptide-1 and Transforming Growth Factor-ß Signaling in Insulin-Positive Differentiation of AR42J Cells

From the Laboratory of Surgical Organogenesis, Children’s Mercy Hospital, Kansas City, Missouri

The differentiation of pancreatic exocrine AR42J cells into insulin-expressing endocrine cells has served as an important model for both endogenous in vivo ß-cell differentiation as well as potential application to ß-cell engineering of progenitor cells. Exogenous activin, possibly working through intracellular smad 2 and/or smad 3, as well as exogenous exendin-4 (a long-acting glucagon-like peptide-1 agonist) have both been shown to induce insulin-positive/endocrine differentiation in AR42J cells. In this study, we present evidence of significant interplay and interdependence of these two pathways as well as potential synergy between the pathways. In particular, insulin-positive differentiation seems to entail an exendin-4–induced drop in smad 2 and elevation in smad 3 in RNA levels. The latter appears to be dependent on endogenous transforming growth factor (TGF)-ß isoform release by the AR42J cells and may serve as a mechanism to promote ß-cell maturation. The drop in smad 2 may mediate early endocrine commitment. The coapplication of exogenous exendin-4 and, specifically, low-dose exogenous TGF-ß1 led to a dramatic 20-fold increase in insulin mRNA levels, supporting a novel synergistic and codependent relationship between exendin-4 signaling and TGF-ß isoform signaling.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. He, I. Usui, K. Ishizuka, Y. Kanatani, K. Hiratani, M. Iwata, A. Bukhari, T. Haruta, T. Sasaoka, and M. Kobayashi Interleukin-1{alpha} Inhibits Insulin Signaling with Phosphorylating Insulin Receptor Substrate-1 on Serine Residues in 3T3-L1 Adipocytes Mol. Endocrinol., January 1, 2006; 20(1): 114 - 124. [Abstract] [Full Text] [PDF]

				K.-H. Yew, M. Hembree, K. Prasadan, B. Preuett, C. McFall, C. Benjes, A. Crowley, S. Sharp, S. Tulachan, S. Mehta, et al. Cross-talk between Bone Morphogenetic Protein and Transforming Growth Factor-{beta} Signaling Is Essential for Exendin-4-induced Insulin-positive Differentiation of AR42J Cells J. Biol. Chem., September 16, 2005; 280(37): 32209 - 32217. [Abstract] [Full Text] [PDF]